Westover Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
Westover Capital Advisors's MRK Position: Q1 2026 in Review
Westover Capital Advisors increased its Merck (MRK) stake by 110% in Q1 2026, buying an estimated $715K and bringing the position to 11,842 shares worth $1.42M. The position accounts for 0.26% of the portfolio, ranked #77.
Westover Capital Advisors first reported a position in MRK in Q2 2013 and has held it in 28 quarters since. The position peaked at $5.73M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Westover Capital Advisors held 11,842 shares of Merck worth $1.42M as of Q1 2026.
- Westover Capital Advisors bought 6,192 Merck shares in Q1 2026, an estimated $715K.
- Merck made up 0.26% of Westover Capital Advisors's portfolio in Q1 2026, its #77 holding.
- Westover Capital Advisors first reported a position in Merck in Q2 2013 and has held it in 28 quarters since.
- Westover Capital Advisors's Merck position peaked at $5.73M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Westover Capital Advisors's 13F filing for Q1 2026, filed 5 May 2026.